Here is a breakdown of major shareholders in TC BioPharm (Holdings) plc ADR (NASDAQ: TCBP)

TC BioPharm (Holdings) plc ADR (NASDAQ: TCBP) is -65.30% lower on its value in year-to-date trading and has touched a low of $0.85 and a high of $155.40 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The TCBP stock was last observed hovering at around $0.94 in the last trading session, with the day’s gains setting it 0.16%.

Currently trading at $1.10, the stock is -35.54% and -66.40% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.05 million and changing 16.91% at the moment leaves the stock -88.63% off its SMA200. TCBP registered -99.03% loss for a year compared to 6-month loss of -90.82%. The firm has a 50-day simple moving average (SMA 50) of $0.45 and a 200-day simple moving average (SMA200) of -$1.07.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

The stock witnessed a -50.89% gain in the last 1 month and extending the period to 3 months gives it a -89.62%, and is 2.80% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 15.49% over the week and 14.78% over the month.

TC BioPharm (Holdings) plc ADR (TCBP) has around 77 employees, a market worth around $0.75M and $3.35M in sales. Profit margin for the company is -53.62%. Distance from 52-week low is 29.40% and -99.29% from its 52-week high. The company has generated returns on investments over the last 12 months (-38.53%).

TC BioPharm (Holdings) plc ADR quarterly earnings per share for the current quarter are estimated at $0.

12 institutions hold shares in TC BioPharm (Holdings) plc ADR (TCBP), with institutional investors hold 0.29% of the company’s shares. Institutions hold 0.29% of the Float.

The top institutional shareholder in the company is Armistice Capital, LLC with over 0.53 million shares valued at $0.29 million. The investor’s holdings represent 6.52% of the TCBP Shares outstanding. As of Jun 29, 2023, the second largest holder is Citadel Advisors Llc with 75295.0 shares valued at $40809.0 to account for 0.93% of the shares outstanding. The other top investors are Renaissance Technologies, LLC which holds 71900.0 shares representing 0.89% and valued at over $38969.0, while Wells Fargo & Company holds 0.16% of the shares totaling 13000.0 with a market value of $7046.0.